Article
Treatment patterns in people with cystic fibrosis: have they changed since the introduction of ivacaftor?
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society - 1 Mar 2022
Granger Emily, Davies Gwyneth, Keogh Ruth H
Abstract excerpt
BACKGROUND: In late 2012, ivacaftor became available in the UK for people with cystic fibrosis (CF) aged 6 years and over with a G551D mutation. Long-term changes in treatment patterns have not previously been reported. We investigated long-term treatment patterns in people with CF with a G551D mutation who took ivacaftor and compared these with non-ivacaftor-treated cohorts using the UK Cystic Fibrosis Registry....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.